Device Trial Radar · NCT07827638
Radial vs Focused Shockwave Therapy for Plantar Fasciitis
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
216
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Nov 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- Homerton University Hospital NHS Foundation TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 18, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn whether focused extracorporeal shockwave therapy (ESWT) provides better outcomes than radial ESWT for adults with plantar fasciitis. It will also learn about the safety and tolerability of both treatments. The main questions it aims to answer are: 1. Does focused ESWT lead to greater improvement in heel pain than radial ESWT? 2. Does focused ESWT improve foot function more than radial ESWT? 3. Do participants experience less discomfort during focused ESWT compared with radial ESWT? 4. What medical problems or side effects occur with either treatment? Researchers will compare focused ESWT to radial ESWT to see whether one treatment offers better clinical outcomes or is better tolerated. Participants will: 1. Receive three shockwave treatment sessions (radial or focused), one week apart 2. Attend clinic follow-up assessments at 6 weeks, 12 weeks, 6 months, and 12 months 3. Complete questionnaires about heel pain and foot function Keep a diary of symptoms, daily pain levels, activity limitations, and any use of pain medication
Conditions
- Plantar Fasciitis, Chronic
Interventions
Focused Shockwave therapyDevice
Patients will be randomly allocated to focused shockwave therapy in clusters. The settings with regards to the waves will be pre-determined and will be the normal setting usually used by the department They will have one session every week for 3 weeks We will chase them up with outcome at 6 weeks, 12 weeks, 6 months and 12months.
Radial shockwave therapyDevice
Patients will be randomly allocated to radial shockwave therapy in clusters The setting for the shockwave will be pre-determined as advised by the literature and manufacturers of the device They will have one session every week for 3 weeks We will chase them up with outcome at 6 weeks, 12 weeks, 6 months and 12months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average Heel pain at 12 weeks using a numerical rating scale ranging from 0 - 10Time frame: 12 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.